Sepsis: Therapeutic Potential of Immunosuppression versus Immunostimulation.

[1]  M. Oka,et al.  Regulation of inflammatory responses by dynamic subcellular localization of RNA-binding protein Arid5a , 2018, Proceedings of the National Academy of Sciences.

[2]  T. Kishimoto,et al.  Arid5a exacerbates IFN-γ–mediated septic shock by stabilizing T-bet mRNA , 2016, Proceedings of the National Academy of Sciences.

[3]  J. Zhao,et al.  CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients. , 2015, American journal of respiratory cell and molecular biology.

[4]  R. Hotchkiss,et al.  The changing immune system in sepsis , 2013, Virulence.

[5]  H. Kiyonari,et al.  Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo , 2013, Proceedings of the National Academy of Sciences.

[6]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[7]  Daniel R. Richards,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[8]  Stephen J. Huang,et al.  Genome-wide transcription profiling of human sepsis: a systematic review , 2010, Critical care.

[9]  T. Martin,et al.  Animal models of acute lung injury , 2008, American journal of physiology. Lung cellular and molecular physiology.